SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 24 Apr · 12:00 IST

Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India Limited has submitted a disclosure to the stock exchange under Regulation 30 of the SEBI Listing Regulations, 2015. This regulation requires listed companies to inform the exchange about material events or developments that could affect investors. The headline does not specify the exact nature or content of the disclosure, so the underlying matter is unclear from the information provided. Shareholders would need to check the full filing or the company's investor communications to understand what was disclosed.

Likely market impact

Without details on the subject of the disclosure, it is not possible to assess any direct impact on shareholders or the stock. Investors should review the full filing on the NSE/BSE portal for clarity.